This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study sample
No power calculations were used. There was no method of sample selection, patients being allocated to the two treatment groups on the basis of a discussion between the treating cardiologist and the parents. Patients were considered to be suitable for either kind of treatment. No details were given of the considerations that might lead the patients to have a particular kind of treatment. 19 children underwent surgical repair and 43 underwent device closure. Apart from the 62 patients in the study there had been an additional 5 patients who had originally been admitted for device closure but who, during transoesophageal echocardiography, were found to be unsuitable. They were excluded from the analysis.
Analysis of effectiveness
The analysis was based on intention to treat. The following primary health outcomes were used: time in hospital, postprocedure pain score, the number of days after which patients resumed preadmission physical activity levels, the amount of concern expressed by the parents, and an echocardiographic evaluation three months after the procedure. The groups were shown to be not comparable. Patients in the device closure group weighed more and were older than those in the surgical closure group, although there was no significant difference between the size of the defects across the two groups.
Effectiveness results
One patient started off having device closure that was unsuccessful and then had successful surgery.
The median time taken in the ICU was 20 hours (IQ range: 18 -21) for patients undergoing surgery and 0 hours for the device closure patients. The median hospital stay was 88 hours (IQ range: 78 -112) for the surgery group compared to 29 hours (IQ range: 28 -39) (p<0.01) for the device closure group. The median post-procedural pain score was higher for the surgery group at 4.9 (IQ range: 3.1 -7.7), compared to 1.2 (IQ range: 0.4 -3.0, p<0.0001) for device closure patients. 13 of the 19 patients needed analgesia after 48 hours in the surgery group compared to none in the device closure group.
One day after the procedure 1/19 of the surgical patients and 14/43 of the device closure patients had resumed preadmission physical activity levels, (p<0.01) and after 1 week 4/19 and 36/43 of the patients had achieved this, (p<0.01).
3 months after the procedure, echocardiography showed a small residual shunt in 4 patients in the device group and none in the surgical group, (p=0.3).
There were two complications in the surgical group and three in the device closure group, one of the latter being left with a left embolic cerebrovascular accident.
As far as parental satisfaction was concerned, one third of both parental groups were concerned about the long term consequences of the procedure.
Clinical conclusions
All effectiveness outcomes favoured device closure over surgical closure.
Measure of benefits used in the economic analysis
No summary measure of benefits was used, and this study is thus a cost-consequences analysis.
Direct costs
Discounting was not carried out as it was not relevant because costs were incurred over a period of less than a year. A bar chart was used to present the following costs for both kinds of procedure: the actual procedure, nursing costs, pathology tests, radiology, and pharmacy. Unit costs and resource quantities were not reported separately. Costs were taken from the hospital records of each patient in the study using the hospital's computerised clinical costing system. No price year was given.
